Atezolizumab + bevacizumab versus sorafenib in patients...

Atezolizumab + bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma: safety results from the Phase III IMbrave150 study

Ducreux, Michel, Zhu, Andrew, Qin, Shukui, Ikeda, Masafumi, Kim, Tae-You, Lim, Ho Yeong, Kudo, Masatoshi, Breder, Valeriy, Merle, Philippe, Kaseb, Ahmed, Li, Daneng, Verret, Wendy, Xu, Zhen, Hernandez
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
73
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(20)30759-5
Date:
August, 2020
File:
PDF, 56 KB
2020
Conversion to is in progress
Conversion to is failed